Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer

ABSTRACT Introduction and objective: We verified the main hematological and biochemical alterations during the chemotherapy treatment for women with cervical cancer. Material and method: A retrospective, analytical and cross-sectional test was performed. The sample consisted of 39 medical records...

Full description

Bibliographic Details
Main Authors: David Felipe B. Araújo, Iago D. L. Cavalcanti, Bruna R. Larrazabal-Hadj-Idris, Adrya Lúcia Peres
Format: Article
Language:English
Published: Sociedade Brasileira de Patologia Clínica 2020-07-01
Series:Jornal Brasileiro de Patologia e Medicina Laboratorial
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100421&tlng=en
_version_ 1818743889678303232
author David Felipe B. Araújo
Iago D. L. Cavalcanti
Bruna R. Larrazabal-Hadj-Idris
Adrya Lúcia Peres
author_facet David Felipe B. Araújo
Iago D. L. Cavalcanti
Bruna R. Larrazabal-Hadj-Idris
Adrya Lúcia Peres
author_sort David Felipe B. Araújo
collection DOAJ
description ABSTRACT Introduction and objective: We verified the main hematological and biochemical alterations during the chemotherapy treatment for women with cervical cancer. Material and method: A retrospective, analytical and cross-sectional test was performed. The sample consisted of 39 medical records of women who underwent chemotherapy in the period from January to December 2016. The effects of hematological toxicities were evaluated according to erythrogram, leukogram, and platelet parameters, in relation to biochemical toxicities, using levels of serum marker (urea, creatinine, transaminases). Results: It was evidenced that among the chemotherapy protocols used, cisplatin showed a leukogram and plateletgram of 1.06 and 2.09 chances, respectively, for the development of leucopenia and thrombocytopenia during treatment. Conclusion: It was not possible to identify the degree of toxicity of the adverse effects of the treatment, because when these effects were registered in the medical record, they appeared without description, making it difficult to evaluate the degree of toxicity presented.
first_indexed 2024-12-18T02:35:35Z
format Article
id doaj.art-6ff26af5ebbe47c39bf130922e4d3709
institution Directory Open Access Journal
issn 1678-4774
language English
last_indexed 2024-12-18T02:35:35Z
publishDate 2020-07-01
publisher Sociedade Brasileira de Patologia Clínica
record_format Article
series Jornal Brasileiro de Patologia e Medicina Laboratorial
spelling doaj.art-6ff26af5ebbe47c39bf130922e4d37092022-12-21T21:23:48ZengSociedade Brasileira de Patologia ClínicaJornal Brasileiro de Patologia e Medicina Laboratorial1678-47742020-07-015610.5935/1676-2444.20200038Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancerDavid Felipe B. Araújohttps://orcid.org/0000-0003-3747-6988Iago D. L. CavalcantiBruna R. Larrazabal-Hadj-IdrisAdrya Lúcia PeresABSTRACT Introduction and objective: We verified the main hematological and biochemical alterations during the chemotherapy treatment for women with cervical cancer. Material and method: A retrospective, analytical and cross-sectional test was performed. The sample consisted of 39 medical records of women who underwent chemotherapy in the period from January to December 2016. The effects of hematological toxicities were evaluated according to erythrogram, leukogram, and platelet parameters, in relation to biochemical toxicities, using levels of serum marker (urea, creatinine, transaminases). Results: It was evidenced that among the chemotherapy protocols used, cisplatin showed a leukogram and plateletgram of 1.06 and 2.09 chances, respectively, for the development of leucopenia and thrombocytopenia during treatment. Conclusion: It was not possible to identify the degree of toxicity of the adverse effects of the treatment, because when these effects were registered in the medical record, they appeared without description, making it difficult to evaluate the degree of toxicity presented.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100421&tlng=enneoplasmantineoplastichematologytoxicity
spellingShingle David Felipe B. Araújo
Iago D. L. Cavalcanti
Bruna R. Larrazabal-Hadj-Idris
Adrya Lúcia Peres
Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
Jornal Brasileiro de Patologia e Medicina Laboratorial
neoplasm
antineoplastic
hematology
toxicity
title Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
title_full Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
title_fullStr Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
title_full_unstemmed Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
title_short Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
title_sort hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
topic neoplasm
antineoplastic
hematology
toxicity
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100421&tlng=en
work_keys_str_mv AT davidfelipebaraujo hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer
AT iagodlcavalcanti hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer
AT brunarlarrazabalhadjidris hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer
AT adryaluciaperes hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer